Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.3.1.48: histone acetyltransferase

This is an abbreviated version!
For detailed information about histone acetyltransferase, go to the full flat file.

Word Map on EC 2.3.1.48

Reaction

acetyl-CoA
+
[protein]-L-lysine
=
CoA
+
[protein]-N6-acetyl-L-lysine

Synonyms

AAPatA, acetyltransferase, histone, Ada2/Ada3/Gcn5 complex, AIB1, amino acid sensing acetyltransferase, AmiPatA, Amir 5672, ARD1, ARD1 acetyltransferase, arginine methyltransferase A, arginine methyltransferase B, arrest defective 1, arrest defective protein 1 acetyltransferase, At3g14980, ATAC2, ATase1, ATase2, cAMP-regulated protein lysine acetyltransferase, Cbp, CBP histone acetyltransferase, CBP/p300, chameau, circadian locomoter output cycles protein kaput, CLOCK, CREB binding protein, CREB-binding protein, CREBBP, east1, ELO3, ELONGATA3, elongator protein 3, ELP3, enhancer-of-asymmetric leaves-two1, Enok, EP300, Esa1, factor acetyltransferase, FAT, Gcn5, GCN5 family KAT, Gcn5 HAT, GCN5 lysine acetyltransferase, GCN5 N acetyltransferase 5, Gcn5 related N-acetyltransferase, GCN5-like acetyltransferase, GCN5-like enzyme, GCN5-related N-acetyltransferase, Gcn5/PCAF histone acetyltransferase, GCN5b, GCN5L2, general control non-derepressible 5, general control non-repressed protein5, general control nonderepressible 5, general control nonrepressed-protein 5, general control of amino acid synthesis 5, GNAT, GNAT-related histone acetyltransferase complex, GTF3C4, H4 lysine acetyltransferase, HAC1, HAG1, HAG3, HAG4, HAG5, HAM1, HAM2, hARD1, HAT, HAT-B, HAT-B complex, Hat1, Hat1p, Hat2, HatB3.I, HBO1, histone (H4 K16) acetyltransferase, histone acetokinase, histone acetyl transferase, histone acetylase, histone acetyltransferase, histone acetyltransferase 1, histone acetyltransferase AtGCN5, histone acetyltransferase B, histone acetyltransferase Tip60, histone acetyltransferase-1, histone acetyltransferases, histone H3 acetyltransferase, histone H4 acetyltransferase, histone H4 lysine 16 acetyltransferase, histone transacetylase, histone/protein lysine acetyltransferase, HIV-1 Tat-interactive protein, hMOF, Hpa2, Hpa3, human acetylase binding to ORC1, Idm1, K (lysine) acetyltransferase 8, K(lysine) acetyltransferase 8, KAT, KAT10, KAT11, KAT12, KAT13A, KAT13B, KAT13C, KAT13D, KAT2, Kat2A, KAT2A/GCN5, Kat2b, KAT3A, KAT3B, KAT4, KAT5, KAT6, KAT6A, KAT6B, KAT7, KAT8, KAT9, Lsy-12, lysine acetyltransferase, lysine acetyltransferase 2, lysine acetyltransferase 2A, lysine acetyltransferase 2B, lysine acetyltransferase 5, lysine acetyltransferase 8, lysine acetyltransferase complex, lysine acetyltransferase p300, lysine acetyltransferases, lysine-acetyltransferase, Mof, monocytic leukemia zinc finger, monocytic leukemia zinc finger protein, More, Morf, MORF histone acetyltransferase, MOZ, MOZ histone acetyltransferase, Moz related factor, Mst1, MtPat, Myb-binding protein 1A, MYBBP1A, MYST, MYST protein lysine acetyltransferase, MYST-related histone acetyltransferase complex, MYST1, MYST2, MYST3, MYST4, N(alpha)-acetyltransferase 10, N-acetyltransferase, N-terminal acetyltransferase, NAA10, NAT, NAT4, NCoA-1, NCoA-3, NCOAT, Nepsilon-lysine acetyltransferase, NuA4, NuA4 histone acetyltransferase, nuclear cytoplasmicO-GlcNAcase and acetyltransferase, nuclear receptor coactivator 1, nuclear receptor coactivator 3, nucleosome-histone acetyltransferase, Nut1, p/CAF, P/CAF histone acetyltransferase, p160, p300, p300 HAT, p300 histone acetyltransferase, p300/CBP, p300/CBP associated factor, p300/CBP histone acetyltransferase, P300/CBP-associated factor, p300/CBP-associated factor (pCAF), p300HAT, PA4534, Pat, PCAF, PCAF histone acetyltransferase, PF11_0192, PfGCN5, PfGCN5 HAT, Piccolo NuA4 complex, protein acetyl-transferase, protein acetyltransferase, Qkf, regulator of Ty1 transposition protein 109, RmtA, RmtB, RPD3, Rtt109, Rv0998, SAS complex, Sas2, Sas3, SRC1, SRC3, Sven 0867, SvePatA, TAF, TAF1, Tat interacting protein of 60 kDa, Tat-interactive protein, 60 kDa, TBP1, TFIIIC90, tGCN5, TgGCN5b, TgMYST-B, Tip60, tumor suppressor histone H3 lysine 23 acetyltransferase, type B histone acetyltransferase, YfmK, zMoz

ECTree

     2 Transferases
         2.3 Acyltransferases
             2.3.1 Transferring groups other than aminoacyl groups
                2.3.1.48 histone acetyltransferase

Engineering

Engineering on EC 2.3.1.48 - histone acetyltransferase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
C732W
mutation abolishes the binding to histone H3
C740W
mutation abolishes the binding to histone H3
D924A
mutation in conserved residues in the histone acetyltransferase domain, abolishes the in vitro acetyltransferase activity
E451Stop
mutation results in the silencing of 35S-NPTII but not the RD29A-LUC transgene
E941Q
mutation in conserved residues in the histone acetyltransferase domain, abolishes the in vitro acetyltransferase activity
M942A
mutation in conserved residues in the histone acetyltransferase domain, diminishes the in vitro acetyltransferase activity
F124A
site-directed mutagenesis
F129A
site-directed mutagenesis
G88A
site-directed mutagenesis, yfmKG88A is found to phenocopy the yfmK mutant most closely in vivo. HbsK41Q is able to bypass the yfmKG88A phenotype, suggesting that the cognate protein is catalytically inactive
Y89A
site-directed mutagenesis
F124A
-
site-directed mutagenesis
-
F129A
-
site-directed mutagenesis
-
G88A
-
site-directed mutagenesis, yfmKG88A is found to phenocopy the yfmK mutant most closely in vivo. HbsK41Q is able to bypass the yfmKG88A phenotype, suggesting that the cognate protein is catalytically inactive
-
Y89A
-
site-directed mutagenesis
-
E355stop
-
site-directed mutagenesis of the Gn5 gene, inactive mutant, the loss of either dGcn5 or dAda2a function results in similar chromosome structural and developmental defects, in dAda2a mutants, the nucleosomal H4 acetylation at lysines 12 and 5 is significantly reduced, while the acetylation established by dAda2b-containing Gcn5 complexes at H3 lysines 9 and 14 is unaffected, overview
C746A
-
site-directed mutagenesis, mutation in the HAT domain, leads to only slightly reduced catalytic activity, but highly reduced cyclin D1 transcription in the cells
D277N
strong decrease in catalytic efficiency
D551G/V582A/D639E
-
random and site-directed mutagenesis
D62A
4fold increase in Km value
D639V
-
random mutagenesis
E187Q
strong decrease in catalytic efficiency
E276Q
strong decrease in catalytic efficiency
E611K
-
random mutagenesis
E649D
-
random mutagenesis
E64A
6fold increase in Km value
E742Q
-
site-directed mutagenesis, mutation in the HAT domain, leads to only slightly reduced catalytic activity, but highly reduced cyclin D1 transcription in the cells
F605L
-
random mutagenesis
G485
-
a HBO1 mutant, which contains a mutation of an invariant glycine in the histone acetyltransferase domain that abolishes enzymatic activity
G923/925D
-
site-directed mutagenesis, mutation in the HAT domain, leads to only slightly reduced catalytic activity, but highly reduced cyclin D1 transcription in the cells
H524Q
-
random mutagenesis
H592R
-
random mutagenesis
H600R
-
random mutagenesis
I511T/M529I
-
random and site-directed mutagenesis
K1358A
-
site directed mutagenesis of lysine 1358 of the p300 acetyltransferase domain reveals that inhibitor binds via a hydrogen bond to this lysine residue in the wild-type, in the mutant no binding leads to total loss of acetyltransferase activity
K136R
K274R
-
mutant is catalytically inactive
K542E/D601G/Y612C
-
random and site-directed mutagenesis
K542E/D639E
-
random and site-directed mutagenesis
K627R/D639E
-
random and site-directed mutagenesis
L503P/D601G
-
random and site-directed mutagenesis
L503P/D601G/Y612C
-
random and site-directed mutagenesis
N504I/Q519L/V572A/V582A
-
random and site-directed mutagenesis
P655R
-
random mutagenesis
Q519R
-
random mutagenesis
R82A/Y122F
S1834A
-
site-directed mutagenesis, the mutant shows no histone acetylation and ICAM-1 gene expression, overview
S1834E
-
site-directed mutagenesis, the mutant shows no histone acetylation and ICAM-1 gene expression, overview
T535A/D551G
-
random and site-directed mutagenesis
T612G
site-directed mutagenesis, the mutant is able to activate a series of alkynyl and azido acyl-CoA for histone acylation. Residue Thr612 is conserved in the PCAF/GCN5 family
V582A
-
random mutagenesis
V582A/D639E
-
random and site-directed mutagenesis
V582A/Y612C
-
random and site-directed mutagenesis
V582D
-
random mutagenesis
V582D/D639V
-
random and site-directed mutagenesis
W199A
3fold increase in Km value
Y1467F
-
the mutant shows a 150fold reduction in catalytic activity relative to wild-type enzyme
Y612C
-
random mutagenesis
Y612C/P655R
-
random and site-directed mutagenesis
Y638A
G657E
-
site-directed mutagenesis, loss-of-function mutation in the HAT catalytic domain of MOZ, mutation of the HAT catalytic domain affects B-lineage differentiation and hematopoietic stem/progenitor cell frequencies, analysis of hematopoietic cell populations in HAT-/-, HAT-/+, and HAT+/+ mice, overview. The HAT activity of MOZ is essential for maintaining the functionality of hematopoietic stem cells
Y891F
-
site-directed mutagenesis, catalytically inactive mutant, stable binding of unacetylated histone H4, useful for purification of the histone protein
G657E
-
site-directed mutagenesis, loss-of-function mutation in the HAT catalytic domain of MOZ, mutation of the HAT catalytic domain affects B-lineage differentiation and hematopoietic stem/progenitor cell frequencies, analysis of hematopoietic cell populations in HAT-/-, HAT-/+, and HAT+/+ mice, overview. The HAT activity of MOZ is essential for maintaining the functionality of hematopoietic stem cells
-
A190S
-
site-directed mutagenesis, mutant of Gcn5, similar kinetics to wild-type
A190T
-
site-directed mutagenesis, mutant of Gcn5, decreased Km for acetyl-CoA
C303A
-
site-directed mutagenesis of Sas3, exchange in zinc finger motif, remaining activity: 4.5% of wild-type activity
C304A
site-directed mutagenesis, the mutant shows activity and pH-dependence similar to the wild-type enzyme
C304S
C304S/E338Q
-
site-directed mutagenesis, the mutant protein is intrinsically unstable and catalytically inactive, the mutant cell is lethal
C306A
-
site-directed mutagenesis of Sas3, exchange in zinc finger motif, remaining activity: 11.1% of wild-type activity
C323A
-
site-directed mutagenesis of Sas3, exchange in zinc finger motif, no remaining activity
D214A
-
site-directed mutagenesis, increased turnover
D287A/D288A
mutation does not substantially change the shape of the kcat-pH profile, suggesting these conserved residues do not function as base catalysts for histone acetylation
D287N
mutation does not substantially change the shape of the kcat-pH profile, suggesting these conserved residues do not function as base catalysts for histone acetylation
D288N
mutation does not substantially change the shape of the kcat-pH profile, suggesting these conserved residues do not function as base catalysts for histone acetylation. Mutant reveals a dramatic 1000fold decrease in kcat/Km for acetyl-CoA
D343V
-
site-directed mutagenesis, the mutant shows reduced histone H4 acetylation compared to the wild-type Esa1
E173Q
-
site-directed mutagenesis, 500-600 decrease in turnover, no effect on substrate binding, Glu173 is the general base catalyst
E299K/E300K/D301K
-
similar activity toward H3 in comparison to wild-type enzyme, more than 10fold reduction in activation by chaperone Vps75
E338Q
E374A/E378A
-
similar activity toward H3 in comparison to wild-type enzyme
E374K/E378K
-
similar activity toward H3 in comparison to wild-type enzyme, more than 10fold reduction in activation by chaperone Vps75
G429E
-
site-directed mutagenesis of Sas3, exchange in acetyl-CoA binding motif, no remaining activity
G431A
-
site-directed mutagenesis of Sas3, exchange in acetyl-CoA binding motif, nearly no remaining activity: 0.8% of wild-type activity
H145A
-
site-directed mutagenesis, altered peptide binding
H319A
-
site-directed mutagenesis of Sas3, exchange in zinc finger motif, nearly no remaining activity: 1.2% of wild-type activity
K262Q
mutant does support growth of yeast cells
K262R
mutant does not support growth of yeast cells, mutant is catalytically inactive
K428A
-
site-directed mutagenesis of Sas3, exchange in acetyl-CoA binding motif, remaining activity: 55.9% of wild-type activity
K56Q
-
mutation of the acetylation site of histone H3, the mutant shows CAG repeat contractions similar to the wild-type enzyme
K56R
-
mutation of the acetylation site of histone H3, regulation of H3K56 acetylation plays a role in preventing CAG repeat contractions, but may not account for the full effect of deleting the RTT109 gene
L254P
-
esa1 mutant (reduced histone H4 acetylation) at 36°C (restrictive temperature) is sensitive to 6-azauracil (inhibitor impeding elongation by lowering nucleotide pools) but shows little effect at 30°C (permissive temperature), gene length dependent defects in transcription
L357H
-
site-directed mutagenesis, the mutant shows 41% reduced histone H4 acetylation compared to the wild-type Esa1
Q426A
-
site-directed mutagenesis of Sas3, exchange in acetyl-CoA binding motif, remaining activity: 38.6% of wild-type activity
W66R
-
site-directed mutagenesis, the mutant shows reduced histone H4 acetylation compared to the wild-type Esa1
Y430A
-
site-directed mutagenesis of Sas3, exchange in acetyl-CoA binding motif, remaining activity: 16.7% of wild-type activity
Y430L
-
site-directed mutagenesis of Sas3, exchange in acetyl-CoA binding motif, remaining activity: 87.0% of wild-type activity
K56Q
-
mutation of the acetylation site of histone H3, the mutant shows CAG repeat contractions similar to the wild-type enzyme
-
K56R
-
mutation of the acetylation site of histone H3, regulation of H3K56 acetylation plays a role in preventing CAG repeat contractions, but may not account for the full effect of deleting the RTT109 gene
-
E703G
the point mutation ablates enzymatic activity, dominant-negative form of GCN5b. Replication arrest observed in ddHAGCN5b(E703G) parasites is due to a reduction in histone acetylation, which in turn leads to dysregulation of the transcriptome
additional information